Latest filing published 01 Nov 2023 for 仁和药业.
杨潇: trading record in brief
杨潇 (board member) discloses dealings in 仁和药业 to SSE / SZSE (CSRC). Between 25 August 2023 and 1 November 2023, the trades on record add up to 9 filings.
Purchases make up the whole of the open-market record (9 purchases, €12.5M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The median purchase comes to €875k. Across 9 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The latest filing, published on 1 November 2023, reports an open-market purchase of €504k in 仁和药业. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 杨潇
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 560,000 sharesA股XSHESZSE:173000007057391260Canonical exit: 30 Jan 2024 (T+90)
- 1,300,000 sharesA股XSHESZSE:173000007054267330Canonical exit: 29 Jan 2024 (T+90)
- 4,427,500 sharesA股XSHESZSE:173000007051128960Canonical exit: 28 Jan 2024 (T+90)
- 3,146,900 sharesA股XSHESZSE:173000006991606460Canonical exit: 27 Dec 2023 (T+90)
- 660,000 sharesA股XSHESZSE:173000006953737440Canonical exit: 19 Dec 2023 (T+90)
- 940,000 sharesA股XSHESZSE:173000006909179360Canonical exit: 6 Dec 2023 (T+90)
- 460,000 sharesA股XSHESZSE:173000006903481820Canonical exit: 4 Dec 2023 (T+90)
- 1,253,100 sharesA股XSHESZSE:173000006862917340Canonical exit: 26 Nov 2023 (T+90)
- 1,020,200 sharesA股XSHESZSE:173000006854778340Canonical exit: 23 Nov 2023 (T+90)
9 of 9 declarations